SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)
CUSIP: 85205L107
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $.0001 per share
- Shares outstanding
- 75,607,738
- Total 13F shares
- 75,052,336
- Share change
- +1,379,218
- Total reported value
- $3,527,065,482
- Put/Call ratio
- 9%
- Price per share
- $46.99
- Number of holders
- 221
- Value change
- +$106,385,453
- Number of buys
- 132
- Number of sells
- 199
Quarterly Holders Quick Answers
What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 85205L107:
Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
|
Company |
1.7%
from 13D/G
|
11,204,799
|
$494,467,780 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
9.6%
|
7,158,871
|
$331,026,195 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
8.3%
|
6,246,071
|
$275,639,112 | — | 31 Mar 2025 | |
| Stephen P. Squinto |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
6,333,277
mixed-class rows
|
$262,384,838 | — | 19 May 2022 | |
| ORBIMED ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
1.3%
from 13F
|
5,599,842
|
$232,561,438 | — | 12 Sep 2022 | |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,832,413
|
$200,690,112 | — | 10 Aug 2021 | |
| Hudson Bay Capital Management LP |
13D/G
13F
|
Company |
5.2%
|
3,936,857
|
$184,992,910 | $0 | 30 Jun 2025 | |
| Deep Track Capital, LP |
13D/G
|
— |
4.6%
|
3,460,756
|
$160,025,357 | $0 | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
2,916,341
|
$128,698,128 | — | 31 Mar 2025 | |
| Jeffrey Lawrence Schwartz |
3/4/5
|
Director |
—
mixed-class rows
|
3,105,653
mixed-class rows
|
$128,405,735 | — | 24 May 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.4%
|
2,582,732
|
$113,977,000 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.8%
|
2,144,814
|
$94,650,642 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.3%
|
1,750,000
|
$77,227,500 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,715,452
|
$75,720,882 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.2%
|
1,670,008
|
$73,713,571 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.2%
|
1,663,483
|
$73,409,505 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.9%
|
1,459,076
|
$64,389,024 | — | 31 Mar 2025 | |
| Fiera Capital Corp |
13F
|
Company |
1.6%
|
1,224,210
|
$54,024,387 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.4%
|
1,064,109
|
$46,959,130 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
1.2%
|
928,819
|
$40,988,782 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
895,575
|
$39,521,757 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.2%
|
876,547
|
$38,682,019 | — | 31 Mar 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.1%
|
868,942
|
$38,347,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
822,806
|
$36,310,418 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
1%
|
758,533
|
$33,474,061 | — | 31 Mar 2025 | |
| Finepoint Capital LP |
13F
|
Company |
0.96%
|
728,602
|
$32,153,206 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.95%
|
717,911
|
$31,678,035 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.79%
|
599,893
|
$28,440,927 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.84%
|
637,446
|
$28,130,492 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.83%
|
626,430
|
$27,644,356 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.83%
|
626,095
|
$27,629,572 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.82%
|
623,663
|
$27,522,248 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.82%
|
616,728
|
$27,216,207 | — | 31 Mar 2025 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.81%
|
615,929
|
$27,181,000 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
614,886
|
$27,134,919 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.74%
|
555,888
|
$24,538,592 | — | 31 Mar 2025 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.7%
|
531,351
|
$23,448,520 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.69%
|
521,367
|
$23,007,925 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.67%
|
503,868
|
$22,235,695 | — | 31 Mar 2025 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.66%
|
500,000
|
$22,065,000 | — | 31 Mar 2025 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
0.61%
|
463,832
|
$20,468,906 | — | 31 Mar 2025 | |
| SOROS FUND MANAGEMENT LLC |
13F
|
Company |
0.6%
|
456,832
|
$20,159,996 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.59%
|
444,373
|
$19,610,180 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.57%
|
432,951
|
$19,106,127 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.49%
|
373,874
|
$16,499,000 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.48%
|
365,860
|
$16,145,402 | — | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.47%
|
354,505
|
$15,644,306 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.41%
|
307,604
|
$13,574,565 | — | 31 Mar 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.4%
|
304,076
|
$13,418,874 | — | 31 Mar 2025 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.37%
|
282,105
|
$12,449,294 | — | 31 Mar 2025 |
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q2 2025
As of 30 Jun 2025,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
221 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,052,336 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GLAZER CAPITAL, LLC, FIL Ltd, STATE STREET CORP, TIG Advisors, LLC, GOLDMAN SACHS GROUP INC, Beryl Capital Management LLC, Magnetar Financial LLC, and First Trust Capital Management L.P..
This page lists
220
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
304
Q2 2025 holders
221
Holder diff
-83
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.